Pancreas

Gastroenterology. 2023;165(6):1547–57.e4

Cook ME, Bruun NH, Davidsen L, Drewes AM, Olesen SS

Multistate model of the natural history of inflammatory pancreatic diseases: A nationwide population-based cohort study


Background and aims: Understanding the nature of inflammatory pancreatic diseases is essential for planning health care system requirements and interventions. The aim of this study was to quantify the trajectories of inflammatory pancreatic diseases and their association with pancreatic cancer in a population-based setting.
Methods: National health registries were used to identify all Danish residents (≥ 18 years) in the period from 2000 through 2018 with incident cases of acute pancreatitis (AP), recurrent acute pancreatitis (RAP), chronic pancreatitis (CP), and pancreatic cancer. The authors used a multistate model to examine transitions from a healthy state to intermediate states of acute pancreatic inflammation (AP and RAP) to chronic states (CP and pancreatic cancer) and, ultimately, death. Results were reported as transition incidence rates per 1000 person-years with 95% confidence intervals [CIs].
Results: There were 4,663,864 individuals included (mean age, 46 years; 51% were women). During a mean follow-up of 16.8 years, 31,396 individuals were diagnosed with incident AP, 5546 with RAP, 8898 with CP, and 18,182 with pancreatic cancer. The cumulative incidence of pancreatitis (acute and chronic) during the study period was 0.80% (95% CI: 0.79–0.80%). The transition incidence rates to CP were 12.1 (95% CI: 8.1–18.1) from AP, 46.8 (95% CI: 31.6–69.3) from RAP, and 0.07 (95% CI: 0.04–0.13) from a healthy state. Similar patterns were observed for transitions to pancreatic cancer. Most patients diagnosed with CP (64.2%) and pancreatic cancer (96.4%) transitioned directly from a healthy state. Among patients with pancreatitis, 41.0% (95% CI: 40.5–41.5%) died during follow-up.

Conclusions: The study findings revealed an increased risk of chronic pancreatitis (CP) and pancreatic cancer in patients with a history of acute pancreatitis. However, most patients with CP and pancreatic cancer transitioned directly from a healthy state.

Prof. Dr. Dr. S.S. Olesen, Center for Pancreatic Diseases, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark, E-Mail: soso@rn.dk

DOI: 10.1053/j.gastro.2023.08.042

Back to overview

this could be of interest:

Lactated Ringer’s use in the first 24 hours of hospitalization is associated with improved outcomes in 999 patients with acute pancreatitis

Am J Gastroenterol. 2023;118(12):2258–66

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomized, open-label, phase 3 trial

Lancet. 2023;402(10409):1272–81

More articles on the topic